Results 171 to 180 of about 1,023,457 (221)

The Role of Muscle Biopsy in the Era of Modern Genomic Medicine-A Review. [PDF]

J Clin Med
Sadeh M, Dabby R.
europepmc   +1 more source

Diabetic Polyneuropathy Patients Exhibit an Altered Skeletal Muscle Proteome Phenotype

PROTEOMICS – Clinical Applications, Volume 20, Issue 6, November 2026.
ABSTRACT Purpose Diabetic polyneuropathy (DPN) is a debilitating complication of diabetes that affects motor nerves and may impair skeletal muscle health. This study investigated skeletal muscle proteomic alterations associated with DPN compared with type 2 diabetes without DPN (T2D) and healthy controls (CON).
Frederik Forsberg Thybo, Karolina Snopek Khan, Jesper Emil Jakobsgaard, Henning Andersen, Kristian Vissing, Johan Palmfeldt   +5 more
wiley   +1 more source

Severe Rhabdomyolysis in the Setting of Influenza A Infection and Clinically Suspected Anti-signal Recognition Particle-Positive Immune-Mediated Necrotizing Myopathy. [PDF]

Cureus
Hoang YNN, Baral S.
europepmc   +1 more source

Active Helicobacter pylori Infection and Atrial Fibrillation in Patients Hospitalized With Acute Myocardial Infarction

Annals of Noninvasive Electrocardiology, Volume 31, Issue 6, November 2026.
In a two‐center cohort of 300 patients hospitalized with acute myocardial infarction, active Helicobacter pylori infection was not significantly associated with atrial fibrillation prevalence (6.7% in infected versus 12.5% in uninfected patients). ABSTRACT Objective Chronic Helicobacter pylori (H. pylori) infection may promote systemic inflammation and
Mohammed Hashem, Martin O. Sundqvist, Jonatan Wärme, Magnus Bäck, Robin Hofmann   +4 more
wiley   +1 more source

Necrotizing Myopathy Presenting With Guillain-Barré-Like Areflexic Paraparesis, Severe Rhabdomyolysis, and Dialysis-Requiring Acute Kidney Injury. [PDF]

Cureus
Baghdasaryan EJ, Soltani H, Lada S, Simpson C, Nathan R.   +4 more
europepmc   +1 more source

Phase 1 Evaluation of the Pharmacokinetics of Sevasemten (EDG‐5506) for Potential Food Effect and Drug–Drug Interaction With a CYP3A4 Moderate Inhibitor

Clinical and Translational Science, Volume 19, Issue 11, November 2026.
ABSTRACT Sevasemten (EDG‐5506) is an investigational, small molecule, in development for the treatment of Becker and Duchenne muscular dystrophy. In vitro data suggest sevasemten is a substrate for cytochrome P450 (CYP)3A4. Here, we investigate whether the pharmacokinetics (PK) of sevasemten are affected when co‐administered with a moderate CYP3A4 ...
Molly Madden, Roxana Donisa Dreghici, Jeffrey A. Silverman   +2 more
wiley   +1 more source

Recurrent Severe Viral-Induced Rhabdomyolysis Associated With Underlying Genetic Variants in a Young Adult: A Case Report. [PDF]

Cureus
Stone AM, Bunch CM, Gauger A, Seela G, Aboumourad N, Maust J, Picardal A, Roschyk CJ, Gonzales BA, Dollard AC, Abdelghani A, Yakey B, Klever RG, Miller J.   +13 more
europepmc   +1 more source

GNE Myopathy: 25 Years After Gene Identification-Facts, Controversies, Enigmas, Prospects. [PDF]

J Clin Med
Mitrani-Rosenbaum S, Argov Z.
europepmc   +1 more source

Diaphragmatic Mitochondrial Myopathy in a Patient-Derived Mouse Model of Barth Syndrome. [PDF]

J Dev Biol
Tentler K, Snider PL, Matias C, Brault JJ, Conway SJ.   +4 more
europepmc   +1 more source